Chronic Hepatitis C and Screening for Hepatocellular Carcinoma

Clinics in Liver Disease

Volumn 10, Issue 4, 2006, Pages 735-752

  Sherman, Morris ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; CANCER DIAGNOSIS; CANCER SCREENING; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; EVALUATION; FOLLOW UP; HEALTH CARE POLICY; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FUNCTION; LIVER TRANSPLANTATION; PERFORMANCE; RADIOFREQUENCY ABLATION; REVIEW; SCREENING TEST;

ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER NEOPLASMS; MASS SCREENING;

EID: 33845360965     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2006.08.010     Document Type: Review

References (64)

1. Chiaramonte M., Stroffolini T., Vian A., et al. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer 85 (1999) 2132-2137
2. Simonetti R.G., Camma C., Fiorello F., et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis: a case-control study. Ann Intern Med 116 (1992) 97-102
3. Stroffolini T., Andreone P., Andriulli A., et al. Characteristics of hepatocellular carcinoma in Italy. J Hepatol 29 (1998) 944-952
4. Yu M.C., Tong M.J., Coursaget P., et al. Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst 82 (1990) 986-987
5. Tanaka K., Ikematsu H., Hirohata T., et al. Hepatitis C virus infection and risk of hepatocellular carcinoma among Japanese: possible role of type 1b (II) infection. J Natl Cancer Inst 88 (1996) 742-746
6. Bellentani S., Dal Morin G., Miglioli L., et al. Natural history of HBV infection: a nine year follow-up of the Dionysius cohort. J Hepatol 36 (2002) 228S
7. Fattovich G., Giustina G., Degos F., et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 112 (1997) 463-472
8. Niederau C., Lange S., Heintges T., et al. Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology 28 (1998) 1687-1695
9. Degos F., Christidis C., Ganne-Carrie N., et al. Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut 47 (2000) 131-136
10. Sun C.A., Wu D.M., Lin C.C., et al. Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: a prospective study of 12,008 men in Taiwan. Am J Epidemiol 157 (2003) 674-682
11. Prorok P.C. Epidemiologic approach for cancer screening: problems in design and analysis of trials. Am J Pediatr Hematol Oncol 14 (1992) 117-128
12. Chalasani N., Said A., Ness R., et al. Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey. Am J Gastroenterol 94 (1999) 2224-2229
13. Trevisani F., Cantarini M.C., Labate A.M., et al. Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survival. Am J Gastroenterol 99 (2004) 1470-1476
14. Sherman M., Peltekian K.M., and Lee C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology 22 (1995) 432-438
15. Mok T.S., Yeo W., Yu S., et al. An intensive surveillance program detected a high incidence of hepatocellular carcinoma among hepatitis B virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography results. J Clin Oncol 23 (2005) 8041-8047
16. McMahon B.J., Bulkow L., Harpster A., et al. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study. Hepatology 32 (2000) 842-846
17. Kramer B.S. General keynote: cancer screening: translation of principles into practice. Gynecol Oncol 88 1 Pt 2 (2003) S71-S74
18. Izuno K., Fujiyama S., Yamasaki K., et al. Early detection of hepatocellular carcinoma associated with cirrhosis by combined assay of des-gamma-carboxy prothrombin and alpha-fetoprotein: a prospective study. Hepatogastroenterology 42 (1995) 387-393
19. Chen J.G., Parkin D.M., Chen Q.G., et al. Screening for liver cancer: results of a randomised controlled trial in Qidong, China. J Med Screen 10 (2003) 204-209
20. Zhang B.H., Yang B.H., and Tang Z.Y. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 130 (2004) 417-422
21. Sarasin F.P., Giostra E., and Hadengue A. Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis. Am J Med 101 (1996) 422-434
22. Arguedas M.R., Chen V.K., Eloubeidi M.A., et al. Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis. Am J Gastroenterol 98 (2003) 679-690
23. Lin O.S., Keeffe E.B., Sanders G.D., et al. Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C. Aliment Pharmacol Ther 19 (2004) 1159-1172
24. Sala M., Llovet J.M., Vilana R., et al. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 40 (2004) 1352-1360
25. Trevisani F., D'Intino P.E., Morselli-Labate A.M., et al. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol 34 (2001) 570-575
26. Pateron D., Ganne N., Trinchet J.C., et al. Prospective study of screening for hepatocellular carcinoma in caucasian patients with cirrhosis. [see comments]. J Hepatol 20 (1994) 65-71
27. Zoli M., Magalotti D., Bianchi G., et al. Efficacy of a surveillance program for early detection of hepatocellular carcinoma. Cancer 78 (1996) 977-985
28. Di Bisceglie A.M., and Hoofnagle J.H. Elevations in serum alpha-fetoprotein levels in patients with chronic hepatitis B. Cancer 64 (1989) 2117-2120
29. Di Bisceglie A.M., Sterling R.K., Chung R.T., et al. Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial. J Hepatol 43 (2005) 434-441
30. Sherman M. Alphafetoprotein: an obituary. J Hepatol 34 (2001) 603-605
31. Oka H., Tamori A., Kuroki T., et al. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology 19 (1994) 61-66
32. Grazi G.L., Mazziotti A., Legnani C., et al. The role of tumor markers in the diagnosis of hepatocellular carcinoma, with special reference to the des-gamma-carboxy prothrombin. Liver Transpl Surg 1 (1995) 249-255
33. Tsai S.L., Huang G.T., Yang P.M., et al. Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma. Hepatology 11 (1990) 481-488
34. Suehiro T., Sugimachi K., Matsumata T., et al. Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma: comparison with alpha-fetoprotein. Cancer 73 (1994) 2464-2471
35. Marrero J.A., Su G.L., Wei W., et al. Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in American patients. Hepatology 37 (2003) 1114-1121
36. Koike Y., Shiratori Y., Sato S., et al. Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients. Cancer 91 (2001) 561-569
37. Kumada T., Nakano S., Takeda I., et al. Clinical utility of Lens culinaris agglutinin-reactive alpha- fetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis. J Hepatol 30 (1999) 125-130
38. Sato Y., Nakata K., Kato Y., et al. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. N Engl J Med 328 (1993) 1802-1806
39. Shiraki K., Takase K., Tameda Y., et al. A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients. Hepatology 22 (1995) 802-807
40. Taketa K., Endo Y., Sekiya C., et al. A collaborative study for the evaluation of lectin-reactive alpha- fetoproteins in early detection of hepatocellular carcinoma. Cancer Res 53 (1993) 5419-5423
41. Hayashi K., Kumada T., Nakano S., et al. Usefulness of measurement of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and recurrence of small hepatocellular carcinoma. Am J Gastroenterol 94 (1999) 3028-3033
42. Okuda K., Tanaka M., Kanazawa N., et al. Evaluation of curability and prediction of prognosis after surgical treatment for hepatocellular carcinoma by lens culinaris agglutinin-reactive alpha-fetoprotein. Int J Oncol 14 (1999) 265-271
43. Chen T.H., Chen C.J., Yen, et al. Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan. Int J Cancer 98 (2002) 257-261
44. Larcos G., Sorokopud H., Berry G., et al. Sonographic screening for hepatocellular carcinoma in patients with chronic hepatitis or cirrhosis: an evaluation. AJR Am J Roentgenol 171 (1998) 433-435
45. In: Bartolozzi C., and Lencioni R. (Eds). Liver malignancies: diagnostic and interventional radiology (1999), Springer-Verlag, Berlin
46. Zhang B., and Yang B. Combined alpha fetoprotein testing and ultrasonography as a screening test for primary liver cancer. J Med Screen 6 (1999) 108-110
47. Kobayashi K., Sugimoto T., Makino H., et al. Screening methods for early detection of hepatocellular carcinoma. Hepatology 5 (1985) 1100-1105
48. Takayasu K., Moriyama N., Muramatsu Y., et al. The diagnosis of small hepatocellular carcinomas: efficacy of various imaging procedures in 100 patients. AJR Am J Roentgenol 155 (1990) 49-54
49. Miller W.J., Baron R.L., Dodd III G.D., et al. Malignancies in patients with cirrhosis: CT sensitivity and specificity in 200 consecutive transplant patients. Radiology 193 (1994) 645-650
50. Trevisani F., De N.S., Rapaccini G., et al. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience). Am J Gastroenterol 97 (2002) 734-744
51. Santagostino E., Colombo M., Rivi M., et al. A 6-month versus a 12-month surveillance for hepatocellular carcinoma in 559 hemophiliacs infected with the hepatitis C virus. Blood 102 (2003) 78-82
52. Bruix J., Sherman M., Practice Guidelines Committee, and American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 42 (2005) 1208-1236
53. Roncalli M., Roz E., Coggi G., et al. The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implications for diagnosis and classification. Hepatology 30 (1999) 1174-1178
54. Iannaccone R., Laghi A., Catalano C., et al. Hepatocellular carcinoma: role of unenhanced and delayed phase multi-detector row helical CT in patients with cirrhosis. Radiology 234 (2005) 460-467
55. Levy I., Greig P.D., Gallinger S., et al. Resection of hepatocellular carcinoma without preoperative tumor biopsy. Ann Surg 234 (2001) 206-209
56. Torzilli G., Minagawa M., Takayama T., et al. Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology 30 (1999) 889-893
57. Kojiro M. Focus on dysplastic nodules and early hepatocellular carcinoma: an Eastern point of view. Liver Transpl 10 Suppl 1 (2004) S3-S8
58. Nakashima T., and Kojiro M. Hepatocellular carcinoma (1987), Springer Verlag, Tokyo
59. Iwasaki M., Furuse J., Yoshino M., et al. Sonographic appearances of small hepatic nodules without tumor stain on contrast-enhanced computed tomography and angiography. J Clin Ultrasound 26 (1998) 303-307
60. Burrel M., Llovet J.M., Ayuso C., et al. MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. Hepatology 38 (2003) 1034-1042
61. Jeong Y.Y., Mitchell D.G., and Kamishima T. Small (< 20 mm) enhancing hepatic nodules seen on arterial phase MR imaging of the cirrhotic liver: clinical implications. AJR Am J Roentgenol 178 (2002) 1327-1334
62. Fracanzani A.L., Burdick L., Borzio M., et al. Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis. Hepatology 34 (2001) 1109-1112
63. Takayama T., Makuuchi M., Hirohashi S., et al. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet 336 (1990) 1150-1153
64. Nakashima Y., Nakashima O., Tanaka M., et al. Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type. Hepatol Res 26 (2003) 142-147